Relief of suffering is a central goal for palliative care. Achievement of this goal can be difficult, however, due to the complex nature of suffering.
Methods
A psychosocial perspective is used to understand suffering and to identify interventions to relieve suffering in patients with advanced disease.
Results
Clinical experience and research suggest that attending to the psychosocial aspects as well as the medical aspects of palliative care has the potential of further reducing the suffering experienced by patients with advanced disease.
Conclusions
Suffering is best viewed as a subjective phenomenon t hat can be influenced by biological, psychological and social processes. Interventions in each of these areas can help to relieve patient suffering.
Get full access to this article
View all access options for this article.
References
1.
ChernyN.I., CoyleN., FoleyK.M.Suffering in the advanced cancer patient: a definition and taxonomy. J Palliat Care.1994; 10: 57–70.
2.
CassellE.The nature of suffering and the goals of medicine. N Engl J Med.1982; 306: 639–645.
3.
CassellE.J.The Nature of Suffering.New York, NY: Oxford University Press; 1991.
4.
ChapmanC.R., GavrinJ.Suffering and its relationship to pain. J Palliat Care.1993; 9: 5–13.
5.
McCormickT.R., ConleyB.J.Patients1 perspectives on dying and on the care of dying patients. West J Med.1995; 163: 236–243.
6.
HindsC.Suffering: a relatively unexplored phenomenon among family caregivers of non-institutionalized patients with cancer. J Adv Nurs.1992; 17: 918–925.
7.
WellischD.K., WolcottD.L., PasnauR.O.An evaluation of the psychosocial problems of the homebound cancer patient: relationship of patient adjustment to family problems. J Psychosoc Oncol.1989; 7: 55–76.
8.
VachonM.L.S., KristjansonL., HigginsonI.Psychosocial issues in palliative care: the patient, the family, and the process and outcome of care. J Pain Symptom Manage.1995; 10: 142–150.
9.
LevyS.M.Humanizing death: psychotherapy with terminally ill patients. In: CostaP.T., VandenBosG.R., eds. Psychological Aspects of Serious Illness: Chronic Conditions, Fatal Diseases, and Clinical Care.Washington, DC: American Psychological Association; 1990: 185–213.
10.
DoyleD.Have we looked beyond the physical and psychosocial?J Pain Symptom Manage.1992; 7: 302–311.
11.
MillerR.D., WalshT.D.Psychosocial aspects of palliative care in advanced cancer. J Pain Symptom Manage.1991; 6: 24–29.
12.
KaasaS., MaltU., HagenS.Psychological distress in cancer patients with advanced disease. Radiother Oncol.1993; 27: 193–197.
13.
HollandJ.C.Anxiety and cancer: the patient and the family. J Clin Psychiatry.1989; 50: 20–25.
14.
FoleyK.M.The treatment of cancer pain. N Engl J Med.1985; 313: 84–95.
15.
MassieM.J.Anxiety, panic and phobias. In: HollandJ.C., RowlandJ.H., eds. Handbook of Psychooncology: Psychological Care of the Patient With Cancer.New York, NY: Oxford University Press; 1989: 300–309.
16.
StrainJ.J., LiebowitzM.R., KleinD.F.Anxiety and panic attacks in the medically ill. Psychiatry Clin North Am.1981; 4: 333–348.
17.
HollisterL.E.Pharmacotherapeutic considerations in anxiety disorders. J Clin Psychiatry.1986; 47: 33–36.
18.
TwycrossR.G., LackS.A.Therapeutics in Terminal Disease.London: Pitman; 1984: 99–103.
19.
BreitbartW.Tardive dyskinesia associated with high-dose intravenous metoclopramide. N Engl J Med.1986; 315: 518–519.
20.
LiebowitzM.R.Imipramine in the treatment of panic disorder and its complications. Psychiatr Clin North Am.1985; 8: 37–47.
21.
PopkinM.K., CalliesA.L., MackenzieT.B.The outcome of antidepressant use in the medically ill. Arch Gen Psychiatry.1985; 42: 1160–1163.
22.
BrueraE., MacmillanK., PitherJ.Effects of morphine on the dyspnea of terminal cancer patients. J Pain Symptom Manage.1990; 5: 341–344.
23.
LoscalzoM., JacobsenP.B.Practical behavioral approaches to effective management of pain and distress. J Psychosoc Oncol.1990; 8: 139–169.
24.
MassieM.J., HollandJ.C.Depression and the cancer patient. J Clin Psychiatry.1990; 51: 12–17.
25.
PlumbM.M., HollandJ.C.Comparative studies of psychological function in patients with advanced cancer. Psychosom Med.1977; 39: 264–276.
26.
EndicottJ.Measurement of depression patients with cancer. Cancer.1983; 53: 2243–2248.
27.
BreitbartW.Suicide in cancer patients. Oncology (Huntingt).1987; 1: 49–55.
28.
BreitbartW.Cancer pain and suicide. In: FoleyK., eds. Advances in Pain Research and Therapy.New York, NY: Raven Press; 1990; 16: 399–412.
29.
StiefelF.C., BreitbartW.S., HollandJ.C.Corticosteroids in cancer: neuropsychiatric complications. Cancer Invest.1989; 7: 479–491.
30.
YoungD.F.Neurological complications of cancer chemotherapy. In: SilversteinA., ed. Neurological Complications of Therapy: Selected Topics.Mount Kisco, NY: Futura Publishing; 1982: 57–113.
31.
AdamsF., QuesadaJ.R., GuttermanJ.U.Neuropsychiatric manifestations of human leukocyte interferon therapy in patients with cancer. JAMA.1984; 252: 938–941.
32.
DenicoffK.D., RubinowD.R., PapaM.Z.The neuropsychiatric effects of treatment with interleukin-2 and lymphokine-activated killer cells. Ann Intern Med.1987; 107: 293–300.
33.
WeddingtonW.W.Delirium and depression associated with amphotericin B. Psychosomatics.1982; 23: 1076–1078.
34.
DeAngelisL.M., DelattreJ., PosnerJ.B.Radiation-induced dementia in patients cured of brain metastases. Neurology.1989; 39: 789–796.
35.
BreitbartW.B.Endocrine-related psychiatric disorders. In: HollandJ.C., RowlandJ.H., eds. Handbook of Psychooncology: Psychological Care of the Patient With Cancer.New York, NY: Oxford University Press; 1989: 356–366.
36.
PosnerJ.B.Nonmetastatic effects of cancer on the nervous system. In: WyngaardenJ.B., SmithL.H., eds. Cecil1s Textbook of Medicine.Philadelphia, Pa: WB Saunders; 1988: 1104–1107.
37.
DonnellyS., WalshD., RybickiL.The symptoms of advanced cancer: identification of clinical and research priorities by assessment of prevalence and severity. J Palliat Care.1995; 11: 27–32.
38.
LynchM.E.The assessment and prevalence of affective disorders in advanced cancer. J Palliat Care.1995; 11: 10–18.
BreitbartW.Psychiatric complications of cancer. In: BrainM.C., BarboneP.P., eds. Current Therapy in Hematology Oncology-3.Toronto and Philadelphia: BC Decker Inc; 1988: 268–274.
FernandezF., AdamsF., HolmesV.F.Methylphenidate for depressive disorders in cancer patients: an alternative to standard antidepressants. Psychosomatics.1987; 28: 455–461.
45.
BurnsM.M., EisendrathS.J.Dextroamphetamine treatment for depression in terminally ill patients. Psychosomatics.1994; 35: 80–83.
46.
BrueraE., ChadwickS., BrenneisC.Methylphenidate associated with narcotics for the treatment of cancer pain. Cancer Treat Rep.1987; 71: 67–70.
47.
ViganoA., WatanabeS., BrueraE.Methylphenidate for the management of somatization in terminal cancer patients. J Pain Symptom Manage.1995; 10: 167–170.
48.
BreitbartW., MermelsteinH.Pemoline: an alternative psychostimulant for the management of depressive disorders in cancer patients. Psychosomatics.1992; 33: 352–356.
49.
DSM IV: Diagnostic and Statistical Manual of Mental Disorders.4th ed.Washington, DC: American Psychiatric Association; 1994.
50.
BreitbartW., BrueraE., ChochinovH.Neuropsychiatric syndromes and psychological symptoms in patients with advanced cancer. J Pain Symptom Manage.1995; 10: 131–141.
de SousaE., JepsonB.A.Midazolam in terminal care. Lancet.1988; 1: 67–68.
60.
OliverD.J.The use of methotrimeprazine in terminal care. Br J Clin Pract.1985; 39: 339–340.
61.
VentafriddaV., RipamontiC., De ConnoF.Symptom prevalence and control during cancer patients1 last days of life. J Palliat Care.1990; 6: 7–11.
62.
FainsingerR., MillerM.J., BrueraE.Symptom control during the last week of life on a Palliative Care Unit. J Palliat Care.1991; 7: 5–11.
63.
SpeckP.W.Spiritual issues in palliative care. In: DoyleD., HanksG.W., MacDonaldN., eds. Oxford Textbook of Palliative Medicine.New York, NY: Oxford University Press; 1993: 517–525.
64.
CoyleN., LoscalzoM., BaileyL.Supportive home care for the advanced cancer patient and family. In: HollandJ.C., RowlandJ.H., eds. Handbook of Psychooncology: Psychological Care of the Patient With Cancer.New York, NY: Oxford University Press; 1989: 598–606.
65.
ViedermanM., PerryS.W.Use of a psychodynamic life narrative in the treatment of depression in the physically ill. Gen Hosp Psychiatry.1980; 3: 177–185.
66.
ChernyN.I., CoyleN., FoleyK.M.The treatment of suffering when patients request elective death. J Palliat Care.1994; 10: 71–79.
67.
GreerS., MooreyS., BaruchJ.D.Adjuvant psychological therapy for patients with cancer: a prospective randomised trial. Br Med J.1992; 304: 675–680.
68.
BascomP.B., TolleS.W.Care of the family when the patient is dying. West J Med.1995; 163: 292–296.
69.
BuckmanR.Communication in palliative care: a practical guide. In: DoyleD., HanksG.W., MacDonaldN., eds. Oxford Textbook of Palliative Medicine.New York, NY: Oxford University Press; 1993: 47–61.
70.
FaulknerA., WebbP., MaguireP.Communication and counseling skills: educating health professionals working in cancer and palliative care. Patient Educ Counseling.1991; 18: 3–7.
71.
SpiegelD.Effects of psychosocial support on patients with metastatic breast cancer. J Psychosoc Oncol.1992; 10: 113–120.
72.
SpiegelD., GlafkidesM.S.Effects of group confrontation with death and dying. Int J Group Psychother.1983; 33: 433–447.
73.
MurrayD.B.Education and training of clergy in palliative care. In: DoyleD., HanksG.W., MacDonaldN., eds. Oxford Textbook of Palliative Medicine.New York, NY: Oxford University Press; 1993: 795–79.
